I. STOCK OPTIONS AND WARRANTS (Details-Warrants Outstanding and Exercisable) - Warrant [Member] - $ / shares |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2019 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
| Warrants Outstanding, Number Outstanding | 250,000 | 250,000 | 250,000 |
| Weighted Average Exercise Price | $ 0.20 | $ 0.20 | $ 0.20 |
| $0.20 [Member] | |||
| Warrants Outstanding, Number Outstanding | 250,000 | ||
| Warrants Outstanding, Weighted Average Remaining Contractual Life (Years) | 3 years 6 months 7 days | ||
| Weighted Average Exercise Price | $ 0.20 | ||
| Warrants Exercisable, Number Exercisable | 250,000 | ||
| Warrants Exercisable, Weighted Average Exercise Price | $ 0.20 |
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|